The DOI matches its Crossref record; 420 of the 420 references it cites were found in a registry or an index.
Molecular Mechanisms of TDP-43 Misfolding and Pathology in Amyotrophic Lateral Sclerosis
Open accessAbstract
TAR DNA binding protein 43 (TDP-43) is a versatile RNA/DNA binding protein involved in RNA-related metabolism. Hyper-phosphorylated and ubiquitinated TDP-43 deposits as inclusion bodies in the brain and spinal cord of the patients with the motor neuron diseases: amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD). While majority of the ALS cases (90-95%) are sporadic (sALS), among the familial ALS cases 5-10% involve the inheritance of mutations in the TARDBP gene and the remaining (90-95%) are due to mutations in other genes such as: C9ORF72, SOD1, FUS, and NEK1 etc. Strikingly however, majority of the sporadic ALS patients (up to 97%) also contain the TDP-43 protein deposited in the neuronal inclusions, which suggests of its pivotal role in the ALS pathology. Thus, unravelling the molecular mechanisms of the TDP-43 pathology, seems central to the ALS therapeutics, hence, we comprehensively review the current understanding of the TDP-43’s pathology in ALS. We discuss the roles of TDP-43’s mutations, its cytoplasmic mis-localization and aberrant post-translational modifications in ALS. Also, we evaluate TDP-43’s amyloid-like in vitro aggregation, its physiological versus pathological oligomerization in vivo, liquid-liquid phase separation (LLPS), and potential prion-like propagation propensity of the TDP-43 inclusions. Finally, we describe the various evolving TDP-43-induced toxicity mechanisms such as the impairment of endocytosis and mitotoxicity etc. and also discuss the emerging strategies towards TDP-43 disaggregation and ALS therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 420
Genin, E. C., Plutino, M., Bannwarth, S., Villa, E., Cisneros‐Barroso, E., Roy, M., Ortega‐Vila, B., Fragaki, K., Lespinasse, F., Pinero‐Martos, E., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505496 · Cited by 199
Mitochondria in Neurodegeneration
Lezi, E., & Swerdlow, R. H. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-94-007-2869-1_12 · Cited by 198
TDP‐43 loss of function increases TFEB activity and blocks autophagosome–lysosome fusion
Xia, Q., Wang, H., Hao, Z., Fu, C., Hu, Q., Gao, F., Ren, H., Chen, D., Han, J., Ying, Z., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201591998 · Cited by 195
The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum
van Langenhove, T., van der Zee, J., & van Broeckhoven, C. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.665471 · Cited by 195
Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q.-X., Masters, C. L., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 195
Poly(ADP-ribose): An organizer of cellular architecture
Leung, A. K. L. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402114 · Cited by 193
FUS and TARDBP but Not SOD1 Interact in Genetic Models of Amyotrophic Lateral Sclerosis
Kabashi, E., Bercier, V., Lissouba, A., Liao, M., Brustein, E., Rouleau, G. A., & Drapeau, P. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002214 · Cited by 190
Yang, C., Tan, W., Whittle, C., Qiu, L., Cao, L., Akbarian, S., & Xu, Z. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015878 · Cited by 189
Wójcik, C., Rowicka, M., Kudlicki, A., Nowis, D., McConnell, E., Kujawa, M., & DeMartino, G. N. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-05-0432 · Cited by 189
Pathological TDP-43 in parkinsonism–dementia complex and amyotrophic lateral sclerosis of Guam
Geser, F., Winton, M. J., Kwong, L. K., Xu, Y., Xie, S. X., Igaz, L. M., Garruto, R. M., Perl, D. P., Galasko, D., Lee, V. M.-Y., et al. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0257-y · Cited by 188
Walker, A. K., Soo, K. Y., Sundaramoorthy, V., Parakh, S., Ma, Y., Farg, M. A., Wallace, R. H., Crouch, P. J., Turner, B. J., Horne, M. K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081170 · Cited by 187
Dormann, D., Capell, A., Carlson, A. M., Shankaran, S. S., Rodde, R., Neumann, M., Kremmer, E., Matsuwaki, T., Yamanouchi, K., Nishihara, M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06211.x · Cited by 186
TDP-43 post-translational modifications in health and disease
Buratti, E. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1439923 · Cited by 186
Partial loss of TDP-43 function causes phenotypes of amyotrophic lateral sclerosis
Yang, C., Wang, H., Qiao, T., Yang, B., Aliaga, L., Qiu, L., Tan, W., Salameh, J., McKenna-Yasek, D. M., Smith, T., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1322641111 · Cited by 185
Zhang, Y.-J., Caulfield, T., Xu, Y.-F., Gendron, T. F., Hubbard, J., Stetler, C., Sasaguri, H., Whitelaw, E. C., Cai, S., Lee, W. C., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt166 · Cited by 185
Reddy, P. H. (2009) · CNS Spectrums · doi:10.1017/s1092852900024901 · Cited by 185
Chen, H.-J., Mitchell, J. C., Novoselov, S., Miller, J., Nishimura, A. L., Scotter, E. L., Vance, C. A., Cheetham, M. E., & Shaw, C. E. (2016) · Brain · doi:10.1093/brain/aww028 · Cited by 181
Inhibition of Drp1/Fis1 interaction slows progression of amyotrophic lateral sclerosis
Joshi, A. U., Saw, N. L., Vogel, H., Cunnigham, A. D., Shamloo, M., & Mochly‐Rosen, D. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708166 · Cited by 180
A role for calpain-dependent cleavage of TDP-43 in amyotrophic lateral sclerosis pathology
Yamashita, T., Hideyama, T., Hachiga, K., Teramoto, S., Takano, J., Iwata, N., Saido, T. C., & Kwak, S. (2012) · Nature Communications · doi:10.1038/ncomms2303 · Cited by 179
Prion-like nuclear aggregation of TDP-43 during heat shock is regulated by HSP40/70 chaperones
Udan-Johns, M., Bengoechea, R., Bell, S., Shao, J., Diamond, M. I., True, H. L., Weihl, C. C., & Baloh, R. H. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt408 · Cited by 177
Oxidative stress and mitochondrial damage: importance in non-SOD1 ALS
Carrì, M. T., Valle, C., Bozzo, F., & Cozzolino, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00041 · Cited by 174
Ataxin-2 repeat-length variation and neurodegeneration
Ross, O. A., Rutherford, N. J., Baker, M., Soto-Ortolaza, A. I., Carrasquillo, M. M., DeJesus-Hernandez, M., Adamson, J., Li, M., Volkening, K., Finger, E., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr227 · Cited by 172
Mass spectrometric analysis of accumulated TDP-43 in amyotrophic lateral sclerosis brains
Kametani, F., Obi, T., Shishido, T., Akatsu, H., Murayama, S., Saito, Y., Yoshida, M., & Hasegawa, M. (2016) · Scientific Reports · doi:10.1038/srep23281 · Cited by 172
Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand
Ramesh, N., & Pandey, U. B. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00263 · Cited by 171
Misregulated RNA processing in amyotrophic lateral sclerosis
Polymenidou, M., Lagier-Tourenne, C., Hutt, K. R., Bennett, C. F., Cleveland, D. W., & Yeo, G. W. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.059 · Cited by 169
Coyne, A. N., Siddegowda, B. B., Estes, P. S., Johannesmeyer, J., Kovalik, T., Daniel, S. G., Pearson, A., Bowser, R. P., & Zarnescu, D. C. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2526-14.2014 · Cited by 169
Trías, E., Ibarburu, S., Barreto‐Núñez, R., Babdor, J., Maciel, T. T., Guillo, M., Gros, L., Dubreuil, P. C., Díaz‐Amarilla, P., Cassina, P., et al. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0620-9 · Cited by 169
TDP‐43 and FUS en route from the nucleus to the cytoplasm
Ederle, H., & Dormann, D. (2017) · FEBS Letters · doi:10.1002/1873-3468.12646 · Cited by 169
NEK1 mutations in familial amyotrophic lateral sclerosis
Brenner, D., Müller, K., Wieland, T., Weydt, P., Böhm, S., Lulé, D. E., Hübers, A., Neuwirth, C., Weber, M., Borck, G., et al. (2016) · Brain · doi:10.1093/brain/aww033 · Cited by 168
VCP mutations in familial and sporadic amyotrophic lateral sclerosis
Koppers, M., van Blitterswijk, M., Vlam, L., Rowicka, P. A., van Vught, P. W. J., Groen, E. J. N., Spliet, W. G. M., Engelen-Lee, J.-Y., Schelhaas, H. J., de Visser, M., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.10.006 · Cited by 167
RNA targets of TDP-43 identified by UV-CLIP are deregulated in ALS
Xiao, S., Sanelli, T., Dib, S., Sheps, D., Findlater, J., Bilbao, J., Keith, J., Zinman, L., Rogaeva, E., & Robertson, J. (2011) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2011.02.013 · Cited by 166
Regulation of Autophagy by Neuropathological Protein TDP-43
Bose, J. K., Huang, C.-C., & Shen, C.-K. J. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.237115 · Cited by 165 · cited 1×
“TDP-43 has been found to be involved in the regulation of autophagy by associating with the mRNA of a key autophagyassociated protein ATG7 (autophagy related 7), however, some of the ALS-linked TDP-43 mutations can abolish its ATG7 mRNA binding ability (Bose et al., 2011).”
BackgroundWilliams, J. R., Trias, E., Beilby, P. R., Lopez, N. I., Labut, E. M., Bradford, C. S., Roberts, B. R., McAllum, E. J., Crouch, P. J., Rhoads, T. W., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.01.020 · Cited by 163
Jiang, L.-L., Che, M.-X., Zhao, J., Zhou, C.-J., Xie, M.-Y., Li, H.-Y., He, J.-H., & Hu, H.-Y. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.463828 · Cited by 162
Zhang, Y., Gendron, T. F., Xu, Y.-F., Ko, L., Yen, S.-H. C., & Petrucelli, L. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-33 · Cited by 162
Archbold, H. C., Jackson, K. L., Arora, A., Weskamp, K., Tank, E. M. H., Li, X., Miguez, R., Dayton, R. D., Tamir, S., Klein, R. L., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22858-w · Cited by 162
Hebron, M. L., Lonskaya, I., Sharpe, K., Weerasinghe, P. P. K., Algarzae, N. K., Shekoyan, A. R., & Moussa, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419945 · Cited by 161
Qin, H., Lim, L.-Z., Wei, Y., & Song, J. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1413994112 · Cited by 160
In vitro prion-like behaviour of TDP-43 in ALS
Smethurst, P., Newcombe, J., Troakes, C., Simone, R., Chen, Y., Patani, R., & Sidle, K. C. L. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.007 · Cited by 159
TDP-43 interacts with mitochondrial proteins critical for mitophagy and mitochondrial dynamics
Davis, S. A., Itaman, S., Khalid-Janney, C. M., Sherard, J. A., Dowell, J. A., Cairns, N. J., & Gitcho, M. A. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.04.053 · Cited by 159
Interaction with Polyglutamine Aggregates Reveals a Q/N-rich Domain in TDP-43
Fuentealba, R. A., Udan, M., Bell, S., Wegorzewska, I., Shao, J., Diamond, M. I., Weihl, C. C., & Baloh, R. H. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.125039 · Cited by 158
The N-terminal dimerization is required for TDP-43 splicing activity
Jiang, L., Xue, W., Hong, J.-Y., Zhang, J.-T., Li, M., Yu, S., He, J., & Hu, H. (2017) · Scientific Reports · doi:10.1038/s41598-017-06263-3 · Cited by 156
The TDP‐43 N‐terminal domain structure at high resolution
Mompeán, M., Romano, V. C., Pantoja‐Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2016) · FEBS Journal · doi:10.1111/febs.13651 · Cited by 153
Blokhuis, A. M., Koppers, M., Groen, E. J. N., van den Heuvel, D. M. A., Modigliani, S. D., Anink, J. J., Fumoto, K., van Diggelen, F., Snelting, A., Sodaar, P., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1575-8 · Cited by 153
Stribl, C., Samara, A., Trümbach, D., Peis, R., Neumann, M., Fuchs, H., Gailus‐Durner, V., de Angelis, M. H., Rathkolb, B., Wolf, E., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515940 · Cited by 151
The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity
Chang, C., Wu, T.-H., Wu, C.-Y., Chiang, M.-H., Toh, E. K.-W., Hsu, Y.-C., Lin, K.-F., Liao, Y.-H., Huang, T.-H., & Huang, J. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.071 · Cited by 150
Loss of function CHCHD10 mutations in cytoplasmic TDP-43 accumulation and synaptic integrity
Woo, J. A., Liu, T., Trotter, C., Fang, C. C., Narvaez, E. D., LePochat, P., Maslar, D., Bukhari, A., Zhao, X., Deonarine, A., et al. (2017) · Nature Communications · doi:10.1038/ncomms15558 · Cited by 150
Nonaka, T., Suzuki, G., Tanaka, Y., Kametani, F., Hirai, S., Okado, H., Miyashita, T., Saitoe, M., Akiyama, H., Masai, H., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695379 · Cited by 146
Lin, W.-L., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0408-9 · Cited by 145
Mutations in the CHCHD10 gene are a common cause of familial amyotrophic lateral sclerosis
Johnson, J. O., Glynn, S. M., Gibbs, J. R., Nalls, M. A., Sabatelli, M., Restagno, G., Drory, V. E., Chiò, A., Rogaeva, E. A., & Traynor, B. J. (2014) · Brain · doi:10.1093/brain/awu265 · Cited by 145
Induction of Amyloid Fibrils by the C-Terminal Fragments of TDP-43 in Amyotrophic Lateral Sclerosis
Chen, A. K.-H., Lin, R. Y., Hsieh, E. Z.-J., Tu, P., Chen, R. P. ‐., Liao, T., Chen, W., Wang, C., & Huang, J. J. (2010) · Journal of the American Chemical Society · doi:10.1021/ja9066207 · Cited by 145
TDP-43 Proteinopathies: Neurodegenerative Protein Misfolding Diseases without Amyloidosis
Kwong, L. K., Uryu, K., Trojanowski, J. Q., & Lee, V. M. ‐. (2007) · Neurosignals · doi:10.1159/000109758 · Cited by 145
TDP-43 Dimerizes in Human Cells in Culture
Shiina, Y., Arima, K., Tabunoki, H., & Satoh, J. (2009) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-009-9489-9 · Cited by 145
Kalmár, B., Lu, C., & Greensmith, L. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.08.003 · Cited by 143
Downregulation of MicroRNA-9 in iPSC-Derived Neurons of FTD/ALS Patients with TDP-43 Mutations
Zhang, Z., Almeida, S., Lu, Y., Nishimura, A. L., Peng, L., Sun, D., Wu, B., Karydas, A. M., Tartaglia, M. C., Fong, J. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076055 · Cited by 142
Russell, A. J., Hartman, J. J., Hinken, A. C., Muci, A. R., Kawas, R. F., Driscoll, L., Godinez, G. L., Lee, K. H., Márquez, D. X., Browne, W. F., et al. (2012) · Nature Medicine · doi:10.1038/nm.2618 · Cited by 142
Mutant TAR DNA-binding protein-43 induces oxidative injury in motor neuron-like cell
Duan, W., Li, X., Shi, J., Guo, Y., Li, Z., & Li, C. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.06.018 · Cited by 140
Seyfried, N. T., Gozal, Y. M., Dammer, E. B., Xia, Q., Duong, D. M., Cheng, D., Lah, J. J., Levey, A. I., & Peng, J. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800390-mcp200 · Cited by 140
Watanabe, S., Kaneko, K., & Yamanaka, K. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.433615 · Cited by 139
Patel, B. K., & Liebman, S. W. (2006) · Journal of Molecular Biology · doi:10.1016/j.jmb.2006.10.069 · Cited by 138
Self-citationAcetylation-induced TDP-43 pathology is suppressed by an HSF1-dependent chaperone program
Wang, P., Wander, C. M., Yuan, C., Bereman, M. S., & Cohen, T. J. (2017) · Nature Communications · doi:10.1038/s41467-017-00088-4 · Cited by 136
Baloh, R. H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08256.x · Cited by 135
Nonaka, T., Arai, T., Buratti, E., Baralle, F. E., Akiyama, H., & Hasegawa, M. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.12.031 · Cited by 134
A90V TDP‐43 variant results in the aberrant localization of TDP‐43 in vitro
Winton, M. J., Deerlin, V. M. V., Kwong, L. K., Yuan, W., McCarty-Wood, E., Yu, C., Schellenberg, G. D., Rademakers, R., Caselli, R. J., Karydas, A., et al. (2008) · FEBS Letters · doi:10.1016/j.febslet.2008.05.024 · Cited by 134
Ubiquilin Modifies TDP-43 Toxicity in a Drosophila Model of Amyotrophic Lateral Sclerosis (ALS)
Hanson, K. A., Kim, S. H., Wassarman, D. A., & Tibbetts, R. S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.078527 · Cited by 133
Dammer, E. B., Fallini, C., Gozal, Y. M., Duong, D. M., Rossoll, W., Xu, P., Lah, J. J., Levey, A. I., Peng, J., Bassell, G. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038658 · Cited by 131
Advances in the characterization of RNA‐binding proteins
Marchese, D., de Groot, N. S., Lorenzo-Gotor, N., Livi, C. M., & Tartaglia, G. G. (2016) · Wiley Interdisciplinary Reviews - RNA · doi:10.1002/wrna.1378 · Cited by 131
King, A., Sweeney, F., Bódi, I., Troakes, C., Maekawa, S., & Al‐Sarraj, S. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01085.x · Cited by 129
ALS-Linked Mutations Enlarge TDP-43-Enriched Neuronal RNA Granules in the Dendritic Arbor
Liu‐Yesucevitz, L., Lin, A. Y., Ebata, A., Boon, J. Y., Reid, W., Xu, Y.-F., Kobrin, K. L., Murphy, G. J., Petrucelli, L., & Wolozin, B. L. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.2350-13.2014 · Cited by 129
Mandrioli, J., D’Amico, R., Zucchi, E., Gessani, A., Fini, N., Fasano, A., Caponnetto, C., Chiò, A., Dalla Bella, E., Lunetta, C., et al. (2018) · Medicine · doi:10.1097/md.0000000000011119 · Cited by 128 · cited 1×
“Efficacy of rapamycin for the ALS treatment is being monitored in phase II clinical trials (Mandrioli et al., 2018).”
Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsy
Yokota, O., Davidson, Y. S., Bigio, E. H., Ishizu, H., Terada, S., Arai, T., Hasegawa, M., Akiyama, H., Sikkink, S. K., Pickering-Brown, S. M., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0702-1 · Cited by 128
Li, H.-R., Chen, T.-C., Hsiao, C.-L., Shi, L., Chou, C., & Huang, J. (2017) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2017.10.001 · Cited by 128
Mutations in SOD1 associated with amyotrophic lateral sclerosis cause novel protein interactions
Kunst, C. B., Mezey, É., Brownstein, M., & Patterson, D. (1997) · Nature Genetics · doi:10.1038/ng0197-91 · Cited by 127
Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives
Bozzo, F., Mirra, A., & Carrì, M. T. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.04.065 · Cited by 127
Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2
Guenther, E. L., Ge, P., Trinh, H., Sawaya, M. R., Cascio, D., Boyer, D. R., Gonen, T., Zhou, Z. H., & Eisenberg, D. S. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0045-5 · Cited by 127
de Carvalho, M. A., Pinto, S., Costa, J. N., Evangelista, T., Ohana, B., & Pinto, A. C. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.498521 · Cited by 125
ALS/FTLD: experimental models and reality
Tan, R. H., Ke, Y. D., Ittner, L. M., & Halliday, G. M. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1666-6 · Cited by 125
TDP-43 skeins show properties of amyloid in a subset of ALS cases
Robinson, J. L., Geser, F., Stieber, A., Umoh, M. E., Kwong, L. K., Deerlin, V. M. V., Lee, V. M. ‐., & Trojanowski, J. Q. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1055-8 · Cited by 122
Kim, S. H., Shi, Y., Hanson, K. A., Williams, L. M., Sakasai, R., Bowler, M. J., & Tibbetts, R. S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m808064200 · Cited by 120
Pesiridis, G. S., Tripathy, K., Tanik, S. A., Trojanowski, J. Q., & Lee, V. M. ‐. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.231118 · Cited by 118
Wang, Y.-T., Kuo, P. H., Chiang, C.-H., Liang, J.-R., Chen, Y., Wang, S., Shen, J., & Yuan, H. S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.438564 · Cited by 118
Iguchi, Y., Katsuno, M., Takagi, S., Ishigaki, S., Niwa, J., Hasegawa, M., Tanaka, F., & Sobue, G. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.002 · Cited by 115
Synergistic effect between proteasome and autophagosome in the clearance of polyubiquitinated TDP‐43
Urushitani, M., Sato, T., Bamba, H., Hisa, Y., & Tooyama, I. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22243 · Cited by 114
A randomized trial of mexiletine in ALS
Weiss, M. D., Macklin, E. A., Simmons, Z., Knox, A., Greenblatt, D. J., Atassi, N., Graves, M. C., Parziale, N., Salameh, J. S., Quinn, C. C., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002507 · Cited by 113
Sun, Y., & Chakrabartty, A. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01088 · Cited by 112
Edaravone and its clinical development for amyotrophic lateral sclerosis
Takei, K., Watanabe, K., Yuki, S., Akimoto, M., Sakata, T., & Palumbo, J. (2017) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.1080/21678421.2017.1353101 · Cited by 112
TDP-43 Phosphorylation by casein kinase Iε promotes oligomerization and enhances toxicity in vivo
Choksi, D. K., Roy, B., Chatterjee, S., Yusuff, T., Bakhoum, M. F., Sengupta, U., Ambegaokar, S. S., Kayed, R., & Jackson, G. R. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt498 · Cited by 111
Hart, M. P., & Gitler, A. D. (2012) · Journal of Neuroscience · doi:10.1523/jneurosci.0996-12.2012 · Cited by 110
TDP‐43 loss of function inhibits endosomal trafficking and alters trophic signaling in neurons
Schwenk, B. M., Hartmann, H., Serdaroglu, A., Schludi, M. H., Hornburg, D., Meissner, F., Orozco, D., Colombo, A. V., Tahirović, S., Michaelsen, M., et al. (2016) · The EMBO Journal · doi:10.15252/embj.201694221 · Cited by 109
Hans, F., Fiesel, F. C., Strong, J. C., Jäckel, S., Rasse, T. M., Geisler, S., Springer, W., Schulz, J. B., Voigt, A., & Kahle, P. J. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561704 · Cited by 108
Russo, A., Scardigli, R., Regina, F. L., Murray, M. E., Romano, N., Dickson, D. W., Wolozin, B. L., Cattaneo, A., & Ceci, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx035 · Cited by 108
Randomized phase 2 trial of NP001, a novel immune regulator
Miller, R. G., Block, G. A., Katz, J., Barohn, R. J., Gopalakrishnan, V., Cudkowicz, M., Zhang, J. R., McGrath, M. S., Ludington, E. A., Appel, S. H., et al. (2015) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000100 · Cited by 106
Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72
Budini, M., Buratti, E., Morselli, E., & Criollo, A. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00170 · Cited by 106
Braun, R. J., Sommer, C., Carmona‐Gutiérrez, D., Khoury, C. M., Ring, J., Büttner, S., & Madeo, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.194852 · Cited by 103
Does a loss of TDP-43 function cause neurodegeneration?
Xu, Z. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-27 · Cited by 103
Chiang, C.-H., Grauffel, C., Wu, L.-S., Kuo, P. H., Doudeva, L. G., Lim, C., Shen, C.-K. J., & Yuan, H. S. (2016) · Scientific Reports · doi:10.1038/srep21581 · Cited by 102
Shodai, A., Morimura, T., Ido, A., Uchida, T., Ayaki, T., Takahashi, R., Kitazawa, S., Suzuki, S., Shirouzu, M., Kigawa, T., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.451849 · Cited by 101
TAR DNA-Binding Protein 43 Accumulation in Protein Aggregate Myopathies
Olivé, M., Janué, A., Moreno, D., Gámez, J., Torrejón-Escribano, B., & Ferrer, I. (2009) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181996d8f · Cited by 101
Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins
Jackrel, M. E., & Shorter, J. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.016113 · Cited by 100
TDP-43 localizes in mRNA transcription and processing sites in mammalian neurons
Casafont, Í., Bengoechea, R., Tapia, O., Berciano, M. T., & Lafarga, M. (2009) · Journal of Structural Biology · doi:10.1016/j.jsb.2009.06.006 · Cited by 99
Capitini, C., Conti, S., Perni, M., Guidi, F., Cascella, R., Poli, A. D., Penco, A., Relini, A., Cecchi, C., & Chiti, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0086720 · Cited by 98
Mechanistic and Structural Insights into the Prion-Disaggregase Activity of Hsp104
Sweeny, E. A., & Shorter, J. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.11.016 · Cited by 98
Jiang, L.-L., Zhao, J., Yin, X.-F., He, W.-T., Yang, H., Che, M., & Hu, H.-Y. (2016) · Scientific Reports · doi:10.1038/srep23928 · Cited by 98
Mompeán, M., Romano, V. C., Pantoja‐Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775965 · Cited by 98
Endocytosis regulates TDP-43 toxicity and turnover
Liu, G., Coyne, A. N., Pei, F., Vaughan, S., Chaung, M., Zarnescu, D. C., & Buchan, J. R. (2017) · Nature Communications · doi:10.1038/s41467-017-02017-x · Cited by 97 · cited 2×
“Impaired endocytosis has been linked with increased TDP-43 aggregation, while enhancing endocytosis was found to reverse the TDP-43 toxicity and the motor neuron dysfunction (Liu et al., 2017).”
BackgroundThe Hsp104 N-Terminal Domain Enables Disaggregase Plasticity and Potentiation
Sweeny, E. A., Jackrel, M. E., Go, M. S., Sochor, M., Razzo, B. M., DeSantis, M. E., Gupta, K., & Shorter, J. (2015) · Molecular Cell · doi:10.1016/j.molcel.2014.12.021 · Cited by 97
Collins, M. A., Riascos, D., Kovalik, T., An, J., Krupa, K., Krupa, K., Hood, B. L., Conrads, T. P., Renton, A. E., Traynor, B. J., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1045-x · Cited by 97
Wang, W., Arakawa, H., Wang, L., Okolo, O. B., Siedlak, S. L., Jiang, Y., Gao, J., Xie, F., Petersen, R. B., & Wang, X. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2016.10.013 · Cited by 97
Bigio, E. H., Wu, J. Y., Deng, H., Bit‐Ivan, E. N., Mao, Q., Ganti, R., Peterson, M., Siddique, N., Geula, C., Siddique, T., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1089-6 · Cited by 94
Shimonaka, S., Nonaka, T., Suzuki, G., Hisanaga, S.-I., & Hasegawa, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.713552 · Cited by 93
Austin, J. A., Wright, G. S. A., Watanabe, S., Grossmann, J. G., Antonyuk, S. V., Yamanaka, K., & Hasnain, S. S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1317317111 · Cited by 91
Boehringer, A. V., Garcia‐Mansfield, K., Singh, G. M., Bakkar, N., Pirrotte, P., & Bowser, R. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-14924-6 · Cited by 91
TDP-43 Promotes Neurodegeneration by Impairing Chromatin Remodeling
Berson, A., Sartoris, A., Nativio, R., Deerlin, V. M. V., Toledo, J. B., Porta, S., Liu, S., Chung, C., Garcia, B. A., Lee, V. M. ‐., et al. (2017) · Current Biology · doi:10.1016/j.cub.2017.10.024 · Cited by 91
Age-Dependent TDP-43-Mediated Motor Neuron Degeneration Requires GSK3, hat-trick, and xmas-2
Sreedharan, J., Neukomm, L. J., Brown, R. H., & Freeman, M. R. (2015) · Current Biology · doi:10.1016/j.cub.2015.06.045 · Cited by 90
Delineation of the Core Aggregation Sequences of TDP‐43 C‐Terminal Fragment
Saini, A., & Chauhan, V. S. (2011) · ChemBioChem · doi:10.1002/cbic.201100427 · Cited by 89
TAR-DNA Binding Protein 43 in Pick Disease
Freeman, S. H., Spires‐Jones, T. L., Hyman, B. T., Growdon, J. H., & Frosch, M. P. (2008) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181609361 · Cited by 89
Molecular mechanism of oxidation‐induced TDP‐43 RRM1 aggregation and loss of function
Chang, C., Chiang, M.-H., Toh, E. K.-W., Chang, C., & Huang, T.-H. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.01.038 · Cited by 88
Full-length TDP-43 and its C-terminal fragments activate mitophagy in NSC34 cell line
Hong, K., Li, Y., Duan, W., Guo, Y., Jiang, H. X., Li, C., & Li, C. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.10.003 · Cited by 88
The Role of TDP-43 in Alzheimer’s Disease
Chang, X., Tan, M., Tan, L., & Yu, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9264-5 · Cited by 88
Senataxin mutations and amyotrophic lateral sclerosis
Hirano, M., Quinzii, C. M., Mitsumoto, H., Hays, A. P., Roberts, J. K., Richard, P., & Rowland, L. P. (2010) · Amyotrophic Lateral Sclerosis · doi:10.3109/17482968.2010.545952 · Cited by 87
Sephton, C. F., Cenik, B., Cenik, B. K., Herz, J., & Yu, G. (2012) · bchm · doi:10.1515/hsz-2012-0115 · Cited by 86
Inhibition of TDP-43 Aggregation by Nucleic Acid Binding
Huang, Y., Lin, K.-F., He, R., Tu, P., Koubek, J., Hsu, Y.-C., & Huang, J. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064002 · Cited by 86
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
Jeon, G. S., Shim, Y., Lee, D., Kim, J.-S., Kang, M., Ahn, S. H., Shin, J.-Y., Geum, D., Hong, Y., & Sung, J. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1218-2 · Cited by 86
β-Amyloid triggers ALS-associated TDP-43 pathology in AD models
Herman, A. M., Khandelwal, P. J., Stanczyk, B. B., Rebeck, G. W., & Moussa, C. (2011) · Brain Research · doi:10.1016/j.brainres.2011.02.052 · Cited by 85
The heat shock response in neurons and astroglia and its role in neurodegenerative diseases
Gil, R. S., Ooi, L., Yerbury, J. J., & Ecroyd, H. W. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0208-6 · Cited by 85
TDP-43 stabilises the processing intermediates of mitochondrial transcripts
Izumikawa, K., Nobe, Y., Yoshikawa, H., Ishikawa, H., Miura, Y., Nakayama, H., Nonaka, T., Hasegawa, M., Egawa, N., Inoue, H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-06953-y · Cited by 82
King, A., Maekawa, S., Bódi, I., Troakes, C., & Al‐Sarraj, S. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2010.01171.x · Cited by 81
Structural Evidence of Amyloid Fibril Formation in the Putative Aggregation Domain of TDP-43
Mompeán, M., Hervás, R., Xu, Y., Tran, T. H., Guarnaccia, C., Buratti, E., Baralle, F. E., Tong, L., Carrión‐Vázquez, M., McDermott, A. E., et al. (2015) · The Journal of Physical Chemistry Letters · doi:10.1021/acs.jpclett.5b00918 · Cited by 78
Zinc induces depletion and aggregation of endogenous TDP-43
Caragounis, A., Price, K. A., Soon, C. P. W., Filiz, G., Masters, C. L., Li, Q., Crouch, P. J., & White, A. R. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.01.035 · Cited by 77
Zhan, L., Xie, Q., & Tibbetts, R. S. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu493 · Cited by 77
Neuronal sensitivity to TDP-43 overexpression is dependent on timing of induction
Cannon, A. D., Yang, B., Knight, J. A., Farnham, I. M., Zhang, Y., Wuertzer, C. A., D’Alton, S., Lin, W.-L., Castanedes‐Casey, M., Rousseau, L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-0979-3 · Cited by 76
Osaka, M., Ito, D., & Suzuki, N. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.02.107 · Cited by 75
TDP-43 Potentiates Alpha-synuclein Toxicity to Dopaminergic Neurons in Transgenic Mice
Tian, T., Huang, C., Tong, J., Yang, M., Zhou, H., & Xia, X. (2011) · International Journal of Biological Sciences · doi:10.7150/ijbs.7.234 · Cited by 74
Zinc binding to RNA recognition motif of TDP-43 induces the formation of amyloid-like aggregates
Garnier, C., Devred, F., Byrne, D., Puppo, R., Roman, A. Y., Malesinski, S., Golovin, A. V., Lebrun, R., Ninkina, N. N., & Tsvetkov, P. O. (2017) · Scientific Reports · doi:10.1038/s41598-017-07215-7 · Cited by 73
Genin, E. C., Bannwarth, S., Lespinasse, F., Ortega-Vila, B., Fragaki, K., Itoh, K., Villa, E., Lacas‐Gervais, S., Jokela, M. E., Auranen, M., et al. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.027 · Cited by 73
Moreno, F., Rabinovici, G. D., Karydas, A., Miller, Z., Hsu, S. C., Legati, A., Fong, J. C., Schonhaut, D. R., Esselmann, H., Watson, C., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0190-6 · Cited by 72
TDP-43 accumulation is common in myopathies with rimmed vacuoles
Küsters, B., van Hoeve, B. J. A., Schelhaas, H. J., Laak, H. T., van Engelen, B. G. M., & Lammens, M. M. Y. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0471-2 · Cited by 72
CK‐2127107 amplifies skeletal muscle response to nerve activation in humans
Andrews, J. A., Mill, J. S., Vijayakumar, V., et al. (2017) · Muscle & Nerve · doi:10.1002/mus.26017 · Cited by 72
Intrinsic disorder in proteins involved in amyotrophic lateral sclerosis
Santamaria, N., Alhothali, M., Alfonso, M. B. H., Breydo, L., & Uversky, V. N. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2416-6 · Cited by 71
Cassel, J. A., & Reitz, A. B. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.03.020 · Cited by 70
The Potential for Transition Metal-Mediated Neurodegeneration in Amyotrophic Lateral Sclerosis
Lovejoy, D. B., & Guillemin, G. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00173 · Cited by 70
Metals in Motor Neuron Diseases
Roos, P. M., Vesterberg, O., & Nordberg, M. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100906 · Cited by 69
Iron Metabolism Disturbance in a French Cohort of ALS Patients
Veyrat‐Durebex, C., Corcia, P., Mucha, A., Benzimra, S., Mallet, C., Gendrot, C., Moreau, C., Devos, D., Piver, É., Pagès, J., et al. (2014) · BioMed Research International · doi:10.1155/2014/485723 · Cited by 69
TDP-43 controls lysosomal pathways thereby determining its own clearance and cytotoxicity
Leibiger, C., Deisel, J., Aufschnaiter, A., Ambros, S., Tereshchenko, M., Verheijen, B. M., Büttner, S., & Braun, R. J. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy066 · Cited by 68 · cited 2×
“Strikingly, the autophagy pathway that contributed to the TDP-43 clearance was also found to increase cytotoxicity (Leibiger et al., 2018).”
BackgroundHwee, D. T., Kennedy, A., Ryans, J., Russell, A. J., Jia, Z., Hinken, A. C., Morgans, D. J., Malik, F. I., & Jasper, J. R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096921 · Cited by 68
Boyd, J. D., Lee-Armandt, J. P., Feiler, M. S., Zaarur, N., Liu, M., Kraemer, B. C., Concannon, J. B., Ebata, A., Wolozin, B. L., & Glicksman, M. A. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113501553 · Cited by 68
Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology
Ash, P. E. A., Dhawan, U., Boudeau, S., Lei, S., Carlomagno, Y., Knobel, M., Al-Mohanna, L. F. A., Boomhower, S. R., Newland, M. C., Sherr, D. H., et al. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy267 · Cited by 68
Inhibition of TDP-43 Accumulation by Bis(thiosemicarbazonato)-Copper Complexes
Parker, S. J., Meyerowitz, J., James, J. L., Liddell, J. R., Nonaka, T., Hasegawa, M., Kanninen, K. M., Lim, S., Paterson, B. M., Donnelly, P. S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042277 · Cited by 67
The N‐Terminal Domain of ALS‐Linked TDP‐43 Assembles without Misfolding
Tsoi, P. S., Choi, K., Leonard, P. G., Sizovs, A., Moosa, M. M., MacKenzie, K. R., Ferreon, J. C., & Ferreon, A. C. M. (2017) · Angewandte Chemie International Edition · doi:10.1002/anie.201706769 · Cited by 67
Tanaka, Y., Nonaka, T., Suzuki, G., Kametani, F., & Hasegawa, M. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw024 · Cited by 66
Failure to Deliver and Translate—New Insights into RNA Dysregulation in ALS
Coyne, A. N., Zaepfel, B. L., & Zarnescu, D. C. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00243 · Cited by 66
Mutihac, R., Alegre‐Abarrategui, J., Gordon, D., Farrimond, L. E., Yamasaki-Mann, M., Talbot, K., & Wade‐Martins, R. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.12.010 · Cited by 65
Prion‐like propagation as a pathogenic principle in frontotemporal dementia
Hock, E., & Polymenidou, M. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13668 · Cited by 65
Amlie‐Wolf, A., Ryvkin, P., Tong, R., Dragomir, I. C., Suh, E. R., Xu, Y., Deerlin, V. M. V., Gregory, B. D., Kwong, L. K., Trojanowski, J. Q., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0141836 · Cited by 64
Ayyadevara, S., Balasubramaniam, M., Kakraba, S., Alla, R., Mehta, J. L., & Reis, R. J. S. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2016.6978 · Cited by 64
A novel CHCHD10 mutation implicates a Mia40‐dependent mitochondrial import deficit in ALS
Lehmer, C., Schludi, M. H., Ransom, L., Greiling, J., Junghänel, M., Exner, N., Riemenschneider, H., van der Zee, J., Broeckhoven, C. V., Weydt, P., et al. (2018) · EMBO Molecular Medicine · doi:10.15252/emmm.201708558 · Cited by 64
Koga, S., Sanchez‐Contreras, M., Josephs, K. A., Uitti, R. J., Graff‐Radford, N., van Gerpen, J. A., Cheshire, W. P., Wszolek, Z. K., Rademakers, R., & Dickson, D. W. (2017) · Movement Disorders · doi:10.1002/mds.26809 · Cited by 63
NP001 regulation of macrophage activation markers in ALS: A phase I clinical and biomarker study
Miller, R. G., Zhang, R., Block, G. A., Katz, J., Barohn, R. J., Kasarskis, E. J., Forshew, D. A., Gopalakrishnan, V., & McGrath, M. S. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.951940 · Cited by 63
Abel, O., Shatunov, A., Jones, A. R., Andersen, P. M., Powell, J. F., & Al‐Chalabi, A. (2013) · JMIR mhealth and uhealth · doi:10.2196/mhealth.2706 · Cited by 60
Zhu, L., Xu, M., Yang, M., Yang, Y., Li, Y., Deng, J., Ruan, L., Liu, J., Du, S., Liu, X., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu409 · Cited by 60
Dang, T. N. T., Lim, N. K.-H., Grubman, A., Li, Q., Volitakis, I., White, A. R., & Crouch, P. J. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00015 · Cited by 58
Overexpression of the essential Sis1 chaperone reduces TDP-43 effects on toxicity and proteolysis
Park, S.-K., Hong, J. Y., Arslan, F., Kanneganti, V., Patel, B. K., Tietsort, A., Tank, E. M. H., Li, X., Barmada, S. J., & Liebman, S. W. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006805 · Cited by 58
Self-citationIshii, T., Kawakami, E., Endo, K., Misawa, H., & Watabe, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0179375 · Cited by 58
Prasad, A., Raju, G., Sivalingam, V., Girdhar, A., Verma, M., Vats, K., Taneja, V., Prabusankar, G., & Patel, B. K. (2016) · Scientific Reports · doi:10.1038/srep39490 · Cited by 56
Self-citationTDP-43 regulatesβ-adducin(Add2) transcript stability
Costessi, L., Porro, F., Iaconcig, A., & Muro, A. F. (2014) · RNA Biology · doi:10.1080/15476286.2014.996081 · Cited by 55
Nihei, Y., Ito, D., & Suzuki, N. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.398099 · Cited by 54
Rabdano, S. O., Izmailov, S. A., Luzik, D. A., Groves, A. T., Podkorytov, I. S., & Skrynnikov, N. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-10574-w · Cited by 54
Arresting Amyloid with Coulomb’s Law: Acetylation of ALS-Linked SOD1 by Aspirin Impedes Aggregation
Abdolvahabi, A., Shi, Y., Rhodes, N. R., Cook, N. P., Martí, A. A., & Shaw, B. F. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2015.01.014 · Cited by 52
Romano, M., Buratti, E., Romano, G., Klima, R., Belluz, L. D. B., Stuani, C., Baralle, F. E., & Feiguin, F. M. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.548859 · Cited by 50
Imbalance of mitochondrial dynamics in Drosophila models of amyotrophic lateral sclerosis
Altanbyek, V., Cha, S.-J., Kang, G.-U., Im, D. S., Lee, S., Kim, H., & Kim, K. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.10.134 · Cited by 50
A novel ALS-associated variant in UBQLN4 regulates motor axon morphogenesis
Edens, B. M., Yan, J., Miller, N., Deng, H., Siddique, T., & Ma, Y. C. (2017) · eLife · doi:10.7554/elife.25453 · Cited by 50
Subcellular Localization of Matrin 3 Containing Mutations Associated with ALS and Distal Myopathy
Iradi, M. C. G., Clare, A. M., Brown, H. H., Janus, C., Lewis, J. M., & Borchelt, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0142144 · Cited by 49
Sun, C., Wang, C. Y.-H., Chen, B. P., He, R., Liu, G. C.-H., Wang, C., Chen, W., Chern, Y., & Huang, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0103644 · Cited by 48
Braun, R. J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00182 · Cited by 47
Chen, W., Lonskaya, I., Hebron, M. L., Ibrahim, Z., Olszewski, R. T., Neale, J. H., & Moussa, C. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddu211 · Cited by 44
RBM45 homo-oligomerization mediates association with ALS-linked proteins and stress granules
Li, Y., Collins, M. A., Geiser, R., Bakkar, N., Riascos, D., & Bowser, R. P. (2015) · Scientific Reports · doi:10.1038/srep14262 · Cited by 44
Association between novel TARDBP mutations and Chinese patients with amyotrophic lateral sclerosis
Xiong, H.-L., Wang, J.-Y., Sun, Y., Wu, J.-J., Chen, Y., Qiao, K., Zheng, Q.-J., Zhao, G., & Wu, Z. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-8 · Cited by 43
Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models
Tauffenberger, A., Chitramuthu, B. P., Bateman, A., Bennett, H. P. J., & Parker, J. A. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds485 · Cited by 43
Mechanistic Insights into Hsp104 Potentiation
Torrente, M. P., Chuang, E., Noll, M. M., Jackrel, M. E., Go, M. S., & Shorter, J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.707976 · Cited by 43
Dardis, A., Zampieri, S., Canterini, S., Newell, K. L., Stuani, C., Murrell, J. R., Ghetti, B. F., Fiorenza, M. T., Bembi, B., & Buratti, E. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0325-4 · Cited by 43
Budini, M., Romano, V. C., Avendaño-Vázquez, S. E., Bembich, S., Buratti, E., & Baralle, F. E. (2012) · Brain Research · doi:10.1016/j.brainres.2012.02.031 · Cited by 42
Self-Assembling Properties of Peptides Derived from TDP-43 C-Terminal Fragment
Saini, A., & Chauhan, V. S. (2014) · Langmuir · doi:10.1021/la404710w · Cited by 42
Dysregulation of chromatin remodelling complexes in amyotrophic lateral sclerosis
Tibshirani, M., Zhao, B., Gentil, B. J., Minotti, S., Marques, C., Keith, J., Rogaeva, E., Zinman, L., Rouaux, C., Robertson, J., et al. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx301 · Cited by 42
Masala, A., Sanna, S., Esposito, S., Rassu, M., Galioto, M., Zinellu, A., Carru, C., Carrì, M. T., Iaccarino, C., & Crosio, C. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.08.009 · Cited by 42
Mutant TDP-43 does not impair mitochondrial bioenergetics in vitro and in vivo
Kawamata, H., Peixoto, P. M. V., Konràd, C., Palomo, G. M., Bredvik, K. G., Gerges, M., Valsecchi, F., Petrucelli, L., Ravits, J., Starkov, A. A., et al. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0180-1 · Cited by 41
Increased iron level in motor cortex of amyotrophic lateral sclerosis patients: An in vivo MR study
Yu, J., Qi, F., Wang, N., Gao, P., Dai, S., Lu, Y., Su, Q., Du, Y., & Che, F. (2014) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2014.906618 · Cited by 40
Electrostatic Repulsion Governs TDP-43 C-terminal Domain Aggregation
Mompeán, M., Chakrabartty, A., Buratti, E., & Laurents, D. V. (2016) · PLoS Biology · doi:10.1371/journal.pbio.1002447 · Cited by 40
Bharathi, V., Girdhar, A., Prasad, A., Meenkshi, V., Taneja, V., & Patel, B. K. (2016) · Yeast · doi:10.1002/yea.3209 · Cited by 38
Self-citationOptineurin mutations in patients with sporadic amyotrophic lateral sclerosis in China
Li, C., Ji, Y., Tang, L., Zhang, N., He, J., Ye, S., Liu, X., & Fan, D. (2015) · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration · doi:10.3109/21678421.2015.1089909 · Cited by 37
Novel TARDBP mutations in Nordic ALS patients
Chiang, H., Andersen, P. M., Tysnes, O., Gredal, O., Christensen, P., & Graff, C. (2012) · Journal of Human Genetics · doi:10.1038/jhg.2012.24 · Cited by 36
Prasad, A., Sivalingam, V., Bharathi, V., Girdhar, A., & Patel, B. K. (2018) · Biochimie · doi:10.1016/j.biochi.2018.05.003 · Cited by 36
Self-citationTirasemtiv amplifies skeletal muscle response to nerve activation in humans
Hansen, R. L., Saikali, K. G., Chou, W., Russell, A. J., Chen, M. M., Vijayakumar, V., Stoltz, R. R., Baudry, S., Enoka, R. M., Morgans, D. J., et al. (2014) · Muscle & Nerve · doi:10.1002/mus.24239 · Cited by 35
Delineating the membrane-disrupting and seeding properties of the TDP-43 amyloidogenic core
Liu, G. C.-H., Chen, B. P., Ye, T.-J., Wang, C., Chen, W., Lee, H., Chan, S. I., & Huang, J. J. (2013) · Chemical Communications · doi:10.1039/c3cc46762g · Cited by 35
Different clinical and neuropathologic phenotypes of familial ALS with A315E TARDBP mutation
Fujita, Y., Ikeda, M., Yanagisawa, T., Senoo, Y., & Okamoto, K. (2011) · Neurology · doi:10.1212/wnl.0b013e318232ab87 · Cited by 35
Mashiko, T., Sakashita, E., Kasashima, K., Tominaga, K., Kuroiwa, K., Nozaki, Y., Matsuura, T., Hamamoto, T., & Endo, H. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712232 · Cited by 35
Cysteine Modifications in the Pathogenesis of ALS
Valle, C., & Carrì, M. T. (2017) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2017.00005 · Cited by 35
Addition of exogenous SOD1 aggregates causes TDP-43 mislocalisation and aggregation
Zeineddine, R., Farrawell, N. E., Lambert-Smith, I. A., & Yerbury, J. J. (2017) · Cell Stress and Chaperones · doi:10.1007/s12192-017-0804-y · Cited by 34
Targeting RNA Binding Proteins Involved in Neurodegeneration
Romano, M., & Buratti, E. (2013) · SLAS DISCOVERY · doi:10.1177/1087057113497256 · Cited by 33
Broeck, L. V., Kleinberger, G., Chapuis, J., Gistelinck, M., Amouyel, P., Broeckhoven, C. V., Lambert, J., Callaerts, P., & Dermaut, B. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.09.001 · Cited by 33
Cited by
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Li, J., Yang, D., Li, Z., Zhao, M., Wang, D., Sun, Z., Wen, P., Dai, Y., Gou, F., Ji, Y., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101817 · Cited by 383
TDP-43 proteinopathies: a new wave of neurodegenerative diseases
de Boer, E. M. J., Orie, V. K., Williams, T., Baker, M. R., De Oliveira, H. M., Polvikoski, T., Silsby, M., Menon, P., van den Bos, M., Halliday, G. M., et al. (2021) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2020-322983 · Cited by 381
The Role of Oxidative Stress in Parkinson’s Disease
Chang, K.-H., & Chen, C.-M. (2020) · Antioxidants · doi:10.3390/antiox9070597 · Cited by 341
Recent Research Trends in Neuroinflammatory and Neurodegenerative Disorders
Cohen, J., Mathew, A., Dourvetakis, K. D., Sanchez-Guerrero, E., Pangeni, R. P., Gurusamy, N., Aenlle, K. K., Ravindran, G., Twahir, A., Isler, D., et al. (2024) · Cells · doi:10.3390/cells13060511 · Cited by 103
“The cytoplasmic mislocalization and aggregation of TDP-43 is a major pathological hallmark for sporadic ALS [204,205].”
BackgroundGarcia Morato, J., Hans, F., von Zweydorf, F., Feederle, R., Elsässer, S. J., Skodras, A. A., Gloeckner, C. J., Buratti, E., Neumann, M., & Kahle, P. J. (2022) · Nature Communications · doi:10.1038/s41467-022-28822-7 · Cited by 94
Metadata
- Authors
- Prasad, A., Bharathi, V., Sivalingam, V., Girdhar, A., & Patel, B. K.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2019-02-14
- Volume
- 12
- Pages
- 25-25
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2911237161
- Cited by
- 774
- References
- 420
- FWCI
- 47.43
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.